{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-276249","form_type":"8-K","ticker":"LCTX","cik":"0000876343","company_name":"Lineage Cell Therapeutics, Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:42.431310+00:00","generated_at":"2026-05-16T22:01:28.558117+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Lineage Cell Therapeutics sells 12M shares at $1.75 to Janus Henderson, grossing $21M","bullets":["Sold 12,000,000 common shares at $1.75 per share to Janus Henderson Investors in a block transaction.","Gross proceeds of $21 million before fees and expenses; net proceeds not disclosed.","Transaction executed under the company's existing at-the-market offering program.","Shares trade on NYSE American under ticker LCTX."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-276249","json":"https://secwatch.observer/filing/0001193125-25-276249.json","markdown":"https://secwatch.observer/filing/0001193125-25-276249.md","text":"https://secwatch.observer/filing/0001193125-25-276249.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/0001193125-25-276249-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/876343/000119312525276249/lctx-20251112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:01:28.558117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}